Psoriasis

Patients with psoriasis are known to have an increased risk of various cardiovascular events. In a new study, researchers evaluated various cardiovascular measures, including atherosclerotic plaque burden,...

Following the success of the reSURFACE clinical program, the US Food and Drug Administration has approved a new treatment option for adults with moderate to severe plaque psoriasis.

The results of a recent study shed light on the potential association between vitamin D and disease severity in patients with psoriasis.

Researchers at the American Academy of Dermatology 2018 Annual Meeting have indicated that cannabis may eventually be used as a topical treatment for various skin conditions.

Previous studies have indicated an association between moderate-to-severe plaque psoriasis and inflammatory bowel disease. In a new study, researchers compared the prevalence of gastrointestinal symptoms in...

No previous studies have compared the health-related quality of life in patients with moderate-to-severe psoriasis and hidradenitis suppurativa.

The FDA has approved a new indication for a drug previously approved for the treatment of adults with moderate-to-severe plaque psoriasis.

Obesity is a known risk factor for psoriasis and psoriatic arthritis. Researchers investigated whether these risks were reduced by bariatric surgery in a recent study.

In a new study, researchers aimed to assess the impact of the severity of psoriasis on the risk for incident type 2 diabetes.

Previous studies have suggested an association between psoriasis and metabolic syndrome. In a recent systematic review and meta-analysis, researchers aimed to establish this potential relationship further. ...